The first patient to receive a breakthrough treatment on the NHS for his aggressive form of leukaemia has said it was ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

Piezoelectric nanoparticles deployed inside immune cells and stimulated remotely by ultrasound can trigger the body's disease ...

We’re starting to understand more that endometrial cancer harbors a number of cell surface markers, including folate receptor ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to respond to targeted therapies. To better understand which patients may respond ...

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either ...

Delcath Systems is upgraded from Hold to Buy as sales stabilize and insider confidence grows. Click here to read an analysis ...

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.